Omron Corp. (OTCMKTS:OMRNY) Short Interest Down 41.5% in December

Omron Corp. (OTCMKTS:OMRNY) saw a large decrease in short interest in December. As of December 31st, there was short interest totaling 8,701 shares, a decrease of 41.5% from the December 15th total of 14,864 shares. Based on an average daily trading volume, of 60,600 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are sold short. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 60,600 shares, the days-to-cover ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

Separately, Zacks Research lowered shares of Omron from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Omron Stock Up 1.3%

OMRNY traded up $0.32 during trading on Thursday, reaching $25.63. 27,407 shares of the stock were exchanged, compared to its average volume of 34,805. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.40 and a current ratio of 2.14. The stock’s 50 day moving average price is $25.42 and its two-hundred day moving average price is $26.43. Omron has a twelve month low of $23.23 and a twelve month high of $34.72. The stock has a market cap of $5.29 billion, a P/E ratio of 26.42, a price-to-earnings-growth ratio of 0.40 and a beta of 0.97.

Omron (OTCMKTS:OMRNY) last posted its earnings results on Friday, November 7th. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.27 by ($0.19). Omron had a net margin of 3.47% and a return on equity of 3.01%. The firm had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.34 billion. Equities analysts expect that Omron will post 0.42 EPS for the current year.

Institutional Investors Weigh In On Omron

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC increased its stake in Omron Corp. (OTCMKTS:OMRNY) by 50.7% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 2,129 shares of the company’s stock after buying an additional 716 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent quarter. Institutional investors own 1.09% of the company’s stock.

Omron Company Profile

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.